watchOS 26 added hypertension alerts to Apple Watch last fall, which you can learn how to enable here. A new report today, however, says Apple has another new high blood pressure feature coming to Apple Watch soon.
Today Digitimes published a new report that highlighted two major upgrades coming to Apple Watch Ultra 4.
But that same report also has some intriguing mentions of a new high blood pressure feature that’s apparently been submitted to the FDA for review.
Apple has added a new high blood pressure notification feature to Apple Watch, sharpening the device’s health-management appeal…The feature has not yet been made available to the public as it remains under review by the US Food and Drug Administration (FDA).
The report isn’t entirely clear on how this new feature differs from the existing hypertension notifications that arrived in watchOS 26.
It also doesn’t specify release timing, though perhaps the mention of the new feature alongside Apple Watch Ultra 4 details suggests it will launch with Apple’s forthcoming models.
Curiously, right after mentioning that the new feature is pending FDA approval, Han writes: “The next stage is expected to focus on noninvasive blood-glucose monitoring and other functions, subject to government approval.”
It sounds like after this unreleased high blood pressure feature arrives, Apple’s next stage of development will focus on blood-glucose monitoring—something that’s long been in the works. But whether this means Apple has had a breakthrough on that front is less clear.
The way this report is written makes it hard to draw any strong conclusions other than on two key points. It’s claiming:
Besides those points, there’s no real detail about the new feature or how a future blood-glucose project might be related.
How would you want to see Apple Watch’s hypertension alerts improved in the future? Let us know in the comments.
FTC: We use income earning auto affiliate links. More.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。